“…It is well known that there is a compromise between sensitivity and resolution in collimated nuclear medicine systems [3,4]. The detectability of the radiopharmaceutical concentration in abnormalities depends on the interplay between various parameters, such as the positron emission tomography (PET) scanner's sensitivity, the amount of activity, the ratio of the target-to-background activity, the size of the target, and the irradiation time, among others [5][6][7][8][9].…”